Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Study of electroreflectance spectrum and Franz-Keldysh effect at metal-GaAs interfaces].

Guang pu xue yu guang pu fen xi = Guang pu·2008

Same author

[Study on electro-degradation of new conjugated polymer PFO-BT15 light emitting diodes].

Guang pu xue yu guang pu fen xi = Guang pu·2008

Same author

Comparison of the curative effects of video assisted thoracoscopic anterior correction and small incision, thoracotomic anterior correction for idiopathic thoracic scoliosis.

Chinese medical journal·2008

Same author

Distribution and sources of mercury in soils from former industrialized urban areas of Beijing, China.

Environmental monitoring and assessment·2008

Same author

[Main flavonoids from Sophora flavescenes].

Yao xue xue bao = Acta pharmaceutica Sinica·2008

Same author

External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean.

Journal of chemical information and modeling·2008

Same journal

Curcumin induces ferroptosis in ovarian cancer cells through the Nrf2/GPX4 regulation axis.

American journal of cancer research·2026

Same journal

microRNA-454 shows anti-angiogenic and anti-metastatic activity in pancreatic ductal adenocarcinoma by targeting LRP6 [Retraction].

American journal of cancer research·2026

Same journal

A novel integrated inflammation response score (IIRS) for predicting all-cause and cardiovascular mortality among cancer survivors.

American journal of cancer research·2026

Same journal

Erratum: IGF2BP2-modified UBE2D1 Interacts with Smad2/3 to Promote the Progression of Breast Cancer.

American journal of cancer research·2026

Same journal

Establishment and validation of a 28-day clinical outcome prediction model for acute promyelocytic leukemia based on an early platelet-coagulation factor combined transfusion strategy.

American journal of cancer research·2026

Same journal

Clinical-pathological characteristics and prognosis of elderly primary liver cancer patients.

American journal of cancer research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 19, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Dendritic cells based immunotherapy.

Na Shang¹, Matteo Figini¹, Junjie Shangguan¹

¹Department of Radiology, Feinberg School of Medicine, Northwestern UniversityChicago, IL, USA.

American Journal of Cancer Research

|November 10, 2017

Summary

This summary is machine-generated.

Optimizing dendritic cell (DC) vaccines for cancer immunotherapy requires enhancing antigen loading and improving migration to lymph nodes (LNs). Intraperitoneal injection may boost DC vaccine efficacy for gastrointestinal cancers by increasing LN homing.

Keywords:

Dendritic cells cancer vaccine hepatocellular carcinoma immunotherapy pancreatic cancer

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Experiment Videos

Last Updated: Feb 19, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Area of Science:

Immunology
Oncology
Biotechnology

Background:

Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating anti-tumor immune responses.
DC-based vaccines represent a promising cancer immunotherapy strategy with systemic treatment potential.
Clinical efficacy of DC vaccines is limited by suboptimal antigen loading and poor migration to draining lymph nodes (LNs).

Purpose of the Study:

To review strategies for optimizing tumor antigen loading onto DCs.
To evaluate vaccine administration methods that enhance DC migration to LNs.
To explore the potential of Intraperitoneal (IP) injection for improving DC vaccine delivery, particularly for gastrointestinal cancers.

Main Methods:

Literature review focusing on DC vaccine priming techniques and administration routes.
Analysis of factors influencing DC homing to draining LNs.
Evaluation of IP injection as a delivery method for DC-based cancer immunotherapy.

Main Results:

Effective antigen loading is critical for DC vaccine potency.
Optimizing DC migration to LNs is essential for therapeutic efficacy.
IP injection shows potential for enhancing DC vaccine delivery and LN homing in gastrointestinal cancer models.

Conclusions:

Improving DC vaccine strategies requires addressing both antigen loading and in vivo migration.
Intraperitoneal administration of DC vaccines may enhance homing to the extensive lymphatic network in the gastrointestinal tract.
Further research into IP-injected DC vaccines could improve outcomes for gastrointestinal malignancies like hepatocellular carcinoma (HCC) and pancreatic adenocarcinoma (PDAC).